Enovis Corp (ENOV) Q3 2026 Earnings Call Transcript
Operator: Good morning. And welcome to the Innovus Third Quarter 26 Earnings Conference Call. All participants will be in ...
Model output · Signal date 2026-11-06
Enovis Corp (ENOV) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Rating · 90D
Unlock rating and forecasts
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
of 5150 stocks scored
Rank correlation · 90D
0.0%
Spearman, 357 dates
Market Cap
$1.57B
small-cap · #8 of 26 peers
Summary
Enovis Corp (ENOV) stock forecast summary
Our AI scores Enovis Corp every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Enovis Corp is a small-cap company with a market capitalization of $1.57B. It ranks number 8 by market capitalization among the 26 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For ENOV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ENOV included.
Price
ENOV price chart and AI forecast
Cross-section · 2026-11-06
How ENOV ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-10-02
Enovis Corp (ENOV) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Valuation & Market
| Metric | ENOV | Rank |
|---|---|---|
| Market Cap | $1.57B | 8/26 |
| P/B Ratio | 1.05x | 16/20 |
| EPS | $-10.06 | – |
| Book Value/Share | $25.89 | – |
| Revenue/Share | $39.99 | – |
| FCF/Share | $1.21 | – |
Profitability & Margins
| Metric | ENOV | Rank |
|---|---|---|
| ROE | -35.3% | 11/19 |
| ROA | -14.1% | 11/19 |
| ROIC | -15.1% | 14/21 |
| Gross Margin | 61.3% | 8/19 |
| Operating Margin | -20.6% | 12/20 |
| Net Margin | -22.9% | 11/18 |
| EBT Margin | -21.8% | 12/20 |
| Tax Rate | -5.0% | – |
Financial Health
| Metric | ENOV | Rank |
|---|---|---|
| Current Ratio | 2.15x | 17/24 |
| Quick Ratio | 1.08x | 19/21 |
| D/E Ratio | 1.50x | 6/23 |
| Financial Leverage | 2.50x | 6/23 |
| Interest Coverage | 0.4x | 7/20 |
| Working Capital | $668M | 6/24 |
Cash Flow
| Metric | ENOV | Rank |
|---|---|---|
| Operating Cash Flow | $259M | 7/24 |
| Free Cash Flow | $70M | 6/15 |
| Capital Spending | -$189M | 13/15 |
| OCF Growth YoY | 19.3% | 4/10 |
| FCF Growth YoY | 205.6% | 2/8 |
| FCF/Sales | 3.0% | 8/15 |
| CapEx/Sales | 8.2% | 2/15 |
Operational Efficiency
| Metric | ENOV | Rank |
|---|---|---|
| Asset Turnover | 0.62x | 10/17 |
| Receivables Turnover | 5.4x | 9/16 |
| Inventory Turnover | 1.4x | 15/21 |
| Fixed Assets Turnover | 4.4x | 10/18 |
| Days Sales Outstanding | 68 days | 8/16 |
| Days Inventory | 254 days | 7/21 |
| Payables Period | 82 days | 7/18 |
| Cash Conversion Cycle | 239 days | 3/14 |
Income Statement
| Metric | ENOV | Rank |
|---|---|---|
| Total Revenue | $2.31B | 4/18 |
| Operating Income | -$475M | 24/24 |
| Net Income | -$527M | 20/20 |
| R&D Expense | $126M | 5/21 |
| SG&A Expense | $1.08B | 6/21 |
| Cost of Goods Sold | $892M | 7/21 |
Dividend & Shareholder Information
| Metric | ENOV | Rank |
|---|---|---|
| Shares Outstanding | 58M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.25B | 33.4% of assets |
| Cash & Short-term Investments | $13M | 0.3% of assets |
| Accounts Receivable | $428M | 11.5% of assets |
| Inventory | $620M | 16.6% of assets |
| Total Liabilities | $2.24B | 60.0% of assets |
| Short-term Debt | $379M | 10.2% of assets |
Quarterly Financial Reports
ENOV quarterly financials and insider trading
Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Enovis Corp (ENOV) industry peers
Companies classified under the same SEC industry code as Enovis Corp (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| ENOV Enovis Corp | $1.57B | |
| ISRG Intuitive Surgical Inc | $156.96B | |
| STE Steris Plc | $24.60B | |
| ZBH Zimmer Biomet Holdings, Inc. | $20.38B | |
| SNN Smith & Nephew Plc | $13.67B | |
| ALGN Align Technology Inc | $11.79B | |
| MSA Msa Safety Inc | $6.56B | |
| ESTA Establishment Labs Holdings Inc. | $2.00B | |
| CDRE Cadre Holdings, Inc. | $1.40B | |
| AVR Anteris Technologies Global Corp. | $555M | |
| SMTI Sanara Medtech Inc. | $290M | |
| INGN Inogen Inc | $160M | |
| LAKE Lakeland Industries Inc | $89M | |
| NTRB Nutriband Inc. | $68M | |
| APT Alpha Pro Tech Ltd | $56M | |
| COCH Envoy Medical, Inc. | $55M | |
| MYO Myomo, Inc. | $48M | |
| MLSS Milestone Scientific Inc. | $27M | |
| LFWD Lifeward Ltd. | $16M | |
| CUPR Cuprina Holdings (Cayman) Ltd | $12M | |
| UEEC United Health Products, Inc. | $10M | |
| RGNT Regentis Biomaterials Ltd. | $8M | |
| CLGN Collplant Biotechnologies Ltd | $7M | |
| BBLG Bone Biologics Corp | $1M | |
| FEED Envue Medical, Inc. | $240K | |
| RBOT Vicarious Surgical Inc. | $10K |
Where ENOV sits on the market map
Industrial Applications and Services · Orthopedic, Prosthetic & Surgical Appliances & Supplies
News
Enovis Corp (ENOV) stock news
Enovis’s (NYSE:ENOV) Q3 2026 earnings results: revenue in line with expectations, stock soars
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q3 2026, with revenue up ...
Enovis Corp (ENOV) Q4 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
FAQ
Enovis Corp (ENOV) stock forecast FAQ
What is the Enovis Corp (ENOV) stock forecast?
Our AI scores Enovis Corp every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Enovis Corp stock predictions?
For ENOV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Enovis Corp forecasts updated?
Enovis Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Enovis Corp's industry peers?
26 issuers in our coverage, ENOV included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.